This is a $8,241,552.00 Delivery Order awarded to the University of Chicago by the National Cancer Institute, a civilian agency within the federal government. The contract is part of a larger indefinite delivery vehicle called the "Cancer Study Cohort Recruitment" contract. The University of Chicago, a private research university, will provide services related to the "CONNECT TASK ORDER 8" requirement. This task order does not have a set-aside designation. The contract has an...
This federal contract award was issued by the Department of Health and Human Services' National Institutes of Health National Cancer Institute to the University of Chicago, a private non-profit educational institution and research university. The $278,842.39 delivery order contract is for infrastructure setup services and is not associated with any set-aside designation. The contract is a task order under a larger Cancer Study Cohort Recruitment indefinite delivery, indefinite quantity (IDIQ)...
This federal contract award, valued at $223,861.02, was issued by the National Cancer Institute (NCI) to the University of Chicago for continued infrastructure setup. The contract is a delivery order under the Cancer Study Cohort Recruitment indefinite delivery/indefinite quantity (IDIQ) contract. The University of Chicago, a renowned private research university, will provide services and support for this infrastructure work, which does not have a set-aside designation. The University of Chicago...
This is a task order awarded by the Department of Health and Human Services (HHS) National Institutes of Health (NIH) National Cancer Institute to the University of Chicago, a private not-for-profit university and research institution. The task order, titled "STUDY PLANNING AND PREPARATION," is part of the larger Cancer Study Cohort Recruitment indefinite-delivery, indefinite-quantity (IDIQ) contract. The task order has a potential value of $1,201,036.59 and a completion date of...
This federal contract award, valued at $28,515,413.00, was issued by the National Cancer Institute (NCI) to the University of Chicago for the "EARLY THERAPEUTICS DEVELOPMENT WITH PHASE II EMPHASIS" effort. The contract is a definitive contract with a cost-no-fee pricing type and does not have a set-aside designation. The University of Chicago, a renowned private research university, will conduct cutting-edge research and provide specialized services in areas critical to national...
This is a $12,000,000.00 cost-no-fee delivery order contract awarded to the University of Chicago by the National Institutes of Health (NIH) to support the Medical Imaging and Data Resource Center (MIDRC) - Medical Imaging in the Biomedical Data Fabric project. The contract has an ultimate completion date of August 20, 2027. The University of Chicago is a renowned private research university that frequently receives substantial federal funding through contracts and grants to support its research...
This is a Cost No Fee definitive contract awarded by the National Cancer Institute (NCI), part of the National Institutes of Health (NIH), to the University of Chicago. The contract, valued at $1,104,181.80, is for the continuation of follow-up of diethylstilbestrol (DES)-exposed cohorts. The contract does not have a set-aside designation. As a major recipient of federal research funding, the University of Chicago conducts cutting-edge research across various disciplines, often in...
This is a $12,383.56 firm fixed price purchase order awarded by the National Cancer Institute, a civilian agency within the Department of Health and Human Services, to the University of Chicago, a private nonprofit research university. The contract is for the development of software and does not have a set-aside designation. The award is associated with a larger Other Transaction Agreement with the Defense Advanced Research Projects Agency (DARPA) focused on research into measurement-based...
The National Cancer Institute, a component of the National Institutes of Health within the Department of Health and Human Services, awarded a $1.16 million firm fixed price purchase order to the University of Chicago. The order is for Pediatric Cancer Data Commons Harmonization services from September 1, 2020 through June 30, 2022. Per the sole source solicitation notice, the University will harmonize pediatric cancer data to facilitate analysis and research, supporting NCI's goal of integrating...
This is a definitive contract awarded by the National Cancer Institute, a civilian agency within the Department of Health and Human Services, to the University of Illinois for preclinical pharmacology and toxicology studies. The contract, valued at $24,207,156.38, does not have a set-aside designation. The University of Illinois, a major public research institution, is conducting research and development work to support the PREVENT Cancer Preclinical Drug Development Program, a structured...